Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Select category
Search this blog
The Value of Drug–Drug Interaction Risk Assessments
Posted on June 28th, 2017 by Sherry Winter in Pharma R&D
Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. Continue reading “The Value of Drug–Drug Interaction Risk Assessments” »
